Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors

Abstract

The -1p/-19q genotype predicted response and favorable outcome following PCV chemotherapy corroborating genetic analysis to guide routine clinical management. However, some cases with intact 1p/19q also had clinical benefit.